Do Patients With AR-V7–Positive Prostate Cancer Benefit from Novel Hormonal Therapies? It All Depends on Definitions

Emmanuel Antonarakis, Howard I. Scher

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)4-6
Number of pages3
JournalEuropean Urology
Volume71
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Prostatic Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Do Patients With AR-V7–Positive Prostate Cancer Benefit from Novel Hormonal Therapies? It All Depends on Definitions. / Antonarakis, Emmanuel; Scher, Howard I.

In: European Urology, Vol. 71, No. 1, 01.01.2017, p. 4-6.

Research output: Contribution to journalEditorial

@article{35db461d903a4d2988cd120a95343c03,
title = "Do Patients With AR-V7–Positive Prostate Cancer Benefit from Novel Hormonal Therapies? It All Depends on Definitions",
author = "Emmanuel Antonarakis and Scher, {Howard I.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.eururo.2016.08.038",
language = "English (US)",
volume = "71",
pages = "4--6",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Do Patients With AR-V7–Positive Prostate Cancer Benefit from Novel Hormonal Therapies? It All Depends on Definitions

AU - Antonarakis, Emmanuel

AU - Scher, Howard I.

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=85002744038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85002744038&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2016.08.038

DO - 10.1016/j.eururo.2016.08.038

M3 - Editorial

C2 - 27591934

AN - SCOPUS:85002744038

VL - 71

SP - 4

EP - 6

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 1

ER -